Managing patients through aggressive cancer therapies.
This session reviewed some of the more serious complications and problems associated with treatment and management of patients with head and neck cancer. Strategies to prevent or reduce the incidence and severity of toxicities were discussed. Additionally, the use of cytoprotective agents was presented, particularly the use of amifostine.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003131:Combined Modality Therapy; D019610:Cytoprotection; D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000379:methods; D006258:Head and Neck Neoplasms / Q000150:complications / Q000523:psychology / Q000628:therapy*; D006801:Humans; D009730:Nursing Assessment; D009859:Oncology Nursing / Q000379:methods; D020011:Protective Agents / Q000627:therapeutic use; D011788:Quality of Life; D011832:Radiation Injuries / Q000209:etiology / Q000517:prevention & control; D011878:Radiotherapy / Q000009:adverse effects* / Q000379:methods
D000970:Antineoplastic Agents; D020011:Protective Agents